Search

everythinglearnresearchcommunity

for

Search:↓

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Stem cell therapy may help treat tough hair loss cases.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Ectodermal dysplasia causes various symptoms and early treatment is important for eye, dental, and skin issues.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil effectively treats female pattern hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Menopause affects hair and skin; more research needed for treatment.

The hairline-lowering surgery was effective, safe, and left patients satisfied with few complications.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.